CD56bright NK cells

GPTKB entity

Statements (52)
Predicate Object
gptkbp:instanceOf natural killer cell subtype
gptkbp:alternativeName CD56brightCD16dim/neg NK cells
immunoregulatory NK cells
gptkbp:cytotoxicity low
gptkbp:decreasedIn gptkb:cancer
chronic viral infections
gptkbp:differentiationPotential can differentiate into CD56dim NK cells
gptkbp:expressedIn CD56 (NCAM1)
low levels of killer-cell immunoglobulin-like receptors (KIRs)
high levels of CD94/NKG2A
gptkbp:expressesLow CD16 (FcγRIII)
gptkbp:firstDescribed 1990s
gptkbp:foundIn gptkb:tonsils
lymph nodes
spleen
peripheral blood
secondary lymphoid tissues
gptkbp:frequencyInBlood ~10% of NK cells
gptkbp:frequencyInLymphNodes >90% of NK cells
gptkbp:function cytokine production
immunoregulation
gptkbp:hasNo gptkb:CD57
high levels of granzyme B
high levels of perforin
https://www.w3.org/2000/01/rdf-schema#label CD56bright NK cells
gptkbp:improves pregnancy
certain autoimmune diseases
gptkbp:lifeStage less mature than CD56dim NK cells
gptkbp:marking gptkb:CD117_(c-Kit)
gptkb:CD62L
gptkb:CD56bright
gptkb:CD27
CCR7
CD16dim/negative
CD94high
KIRlow
NKG2Ahigh
gptkbp:proliferationCapacity high
gptkbp:proportionOfNKCells ~10%
gptkbp:response gptkb:IL-15
gptkb:IL-2
gptkb:IL-12
gptkb:IL-18
gptkbp:role early immune response
regulation of adaptive immunity
gptkbp:secretes gptkb:TNF-alpha
gptkb:GM-CSF
gptkb:IL-10
gptkb:IFN-gamma
gptkbp:studiedIn immunotherapy research
gptkbp:bfsParent gptkb:NK_cells
gptkbp:bfsLayer 7